John F Sheridan Insider Trading $TNDM TANDEM DIABETES CARE INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John F Sheridan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John F Sheridan. John F Sheridan is EVP of Research & Dev Ops in Volcano Corp ($VOLC) and Exec. VP of Research & Develop in Volcano Corp ($VOLC) and EVP & CHIEF OPERATING OFFICER in TANDEM DIABETES CARE INC ($TNDM) and EVP, CHIEF OPERATING OFFICER in TANDEM DIABETES CARE INC ($TNDM) and PRESIDENT & CEO in TANDEM DIABETES CARE INC ($TNDM) and Director in Acutus Medical, Inc. ($AFIB).
John F Sheridan in TANDEM DIABETES CARE INC
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of John F Sheridan: PRESIDENT & CEO, EVP, CHIEF OPERATING OFFICER, EVP & CHIEF OPERATING OFFICER
Holdings: 7,331 shares
Current Value: $17,594
Latest Transaction: Jun 01 2021
$TNDM Market Capitalization: $70.48M
$TNDM Previous Close: $2.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of John F Sheridan in TANDEM DIABETES CARE INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AFIB, TNDM, VOLC
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 01 2021 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Option Exercise | M | 0.00 | 3,279 | 0 | 9,837 | |
| Jun 01 2021 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Payment of Exercise | F | 85.65 | 1,134 | 97,127 | 6,197 | 7.3 K to 6.2 K (-15.47 %) |
| Jun 01 2021 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Buy | M | 0.00 | 3,279 | 0 | 7,331 | 4.1 K to 7.3 K (+80.92 %) |
| Oct 15 2020 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Option Exercise | M | 18.86 | 15,000 | 282,900 | 75,000 | |
| Oct 15 2020 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Sell | S | 122.41 | 3,223 | 394,520 | 3,756 | 7 K to 3.8 K (-46.18 %) |
| Oct 15 2020 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Sell | S | 121.78 | 5,380 | 655,192 | 6,979 | 12.4 K to 7 K (-43.53 %) |
| Oct 15 2020 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Sell | S | 120.36 | 6,397 | 769,945 | 12,359 | 18.8 K to 12.4 K (-34.11 %) |
| Oct 15 2020 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Buy | M | 18.86 | 15,000 | 282,900 | 18,756 | 3.8 K to 18.8 K (+399.36 %) |
| Sep 17 2020 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Option Exercise | M | 18.86 | 401 | 7,563 | 90,000 | |
| Sep 17 2020 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Option Exercise | M | 18.86 | 9,599 | 181,037 | 90,401 | |
| Sep 17 2020 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Sell | S | 110.37 | 401 | 44,258 | 3,756 | 4.2 K to 3.8 K (-9.65 %) |
| Sep 17 2020 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Buy | M | 18.86 | 401 | 7,563 | 4,157 | 3.8 K to 4.2 K (+10.68 %) |
| Sep 17 2020 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Sell | S | 110.00 | 9,599 | 1,055,922 | 3,756 | 13.4 K to 3.8 K (-71.88 %) |
| Sep 17 2020 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Buy | M | 18.86 | 9,599 | 181,037 | 13,355 | 3.8 K to 13.4 K (+255.56 %) |
| Aug 04 2020 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Option Exercise | M | 9.00 | 6,653 | 59,877 | 2,180 | |
| Aug 04 2020 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Option Exercise | M | 23.00 | 16,920 | 389,160 | 0 | |
| Aug 04 2020 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Option Exercise | M | 11.06 | 7,960 | 88,030 | 0 | |
| Aug 04 2020 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Option Exercise | M | 2.59 | 1,667 | 4,318 | 0 | |
| Aug 04 2020 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Sell | S | 103.02 | 100 | 10,302 | 3,756 | 3.9 K to 3.8 K (-2.59 %) |
| Aug 04 2020 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Sell | S | 102.20 | 33,100 | 3,382,929 | 3,856 | 37 K to 3.9 K (-89.57 %) |
| Aug 04 2020 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Buy | M | 9.00 | 6,653 | 59,877 | 36,956 | 30.3 K to 37 K (+21.95 %) |
| Aug 04 2020 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Buy | M | 23.00 | 16,920 | 389,160 | 30,303 | 13.4 K to 30.3 K (+126.43 %) |
| Aug 04 2020 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Buy | M | 11.06 | 7,960 | 88,038 | 13,383 | 5.4 K to 13.4 K (+146.78 %) |
| Aug 04 2020 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Buy | M | 2.59 | 1,667 | 4,318 | 5,423 | 3.8 K to 5.4 K (+44.38 %) |
| May 29 2020 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Option Exercise | A | 82.34 | 30,272 | 2,492,596 | 30,272 | |
| May 29 2020 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Option Exercise | A | 0.00 | 13,116 | 0 | 13,116 | |
| May 29 2020 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Option Exercise | A | 82.34 | 30,272 | 2,492,596 | 30,272 | |
| May 29 2020 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Option Exercise | A | 0.00 | 13,116 | 0 | 13,116 | |
| May 19 2020 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Grant | A | 16.93 | 1,255 | 21,247 | 3,756 | 2.5 K to 3.8 K (+50.18 %) |
| Feb 24 2020 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Option Exercise | M | 2.59 | 30,000 | 77,700 | 1,667 | |
| Feb 24 2020 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Sell | S | 89.62 | 700 | 62,736 | 2,501 | 3.2 K to 2.5 K (-21.87 %) |
| Feb 24 2020 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Sell | S | 88.38 | 12,842 | 1,134,955 | 3,201 | 16 K to 3.2 K (-80.05 %) |
| Feb 24 2020 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Sell | S | 87.39 | 16,458 | 1,438,195 | 16,043 | 32.5 K to 16 K (-50.64 %) |
| Feb 24 2020 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Buy | M | 2.59 | 30,000 | 77,700 | 32,501 | 2.5 K to 32.5 K (+1,199.52 %) |
| Nov 26 2019 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Option Exercise | M | 2.59 | 462 | 1,197 | 31,667 | |
| Nov 26 2019 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Sell | S | 70.00 | 462 | 32,340 | 2,501 | 3 K to 2.5 K (-15.59 %) |
| Nov 26 2019 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Buy | M | 2.59 | 462 | 1,197 | 2,963 | 2.5 K to 3 K (+18.47 %) |
| Sep 09 2019 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Option Exercise | M | 2.59 | 9,538 | 24,703 | 32,129 | |
| Sep 09 2019 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Sell | S | 70.03 | 9,538 | 667,946 | 2,501 | 12 K to 2.5 K (-79.23 %) |
| Sep 09 2019 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Buy | M | 2.59 | 9,538 | 24,703 | 12,039 | 2.5 K to 12 K (+381.37 %) |
| May 17 2019 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Grant | A | 16.93 | 1,835 | 31,067 | 2,501 | 666 to 2.5 K (+275.53 %) |
| May 17 2019 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | PRESIDENT & CEO | Grant | A | 16.93 | 1,835 | 31,067 | 2,501 | 666 to 2.5 K (+275.53 %) |
| Feb 27 2019 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP, CHIEF OPERATIN ... | Option Exercise | M | 9.00 | 1,667 | 15,003 | 8,333 | |
| Feb 27 2019 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP, CHIEF OPERATIN ... | Option Exercise | M | 2.59 | 18,333 | 47,482 | 41,667 | |
| Feb 27 2019 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP, CHIEF OPERATIN ... | Option Exercise | A | 48.36 | 105,000 | 5,077,800 | 105,000 | |
| Feb 27 2019 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP, CHIEF OPERATIN ... | Sell | S | 62.53 | 3,800 | 237,614 | 666 | 4.5 K to 666 (-85.09 %) |
| Feb 27 2019 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP, CHIEF OPERATIN ... | Sell | S | 61.91 | 16,200 | 1,002,942 | 4,466 | 20.7 K to 4.5 K (-78.39 %) |
| Feb 27 2019 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP, CHIEF OPERATIN ... | Buy | M | 9.00 | 1,667 | 15,003 | 20,666 | 19 K to 20.7 K (+8.77 %) |
| Feb 27 2019 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP, CHIEF OPERATIN ... | Buy | M | 2.59 | 18,333 | 47,482 | 18,999 | 666 to 19 K (+2,752.70 %) |
| Feb 20 2019 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP, CHIEF OPERATIN ... | Option Exercise | A | 51.50 | 105,000 | 5,407,500 | 105,000 | |
| Jan 25 2019 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP, CHIEF OPERATIN ... | Option Exercise | M | 2.59 | 20,000 | 51,800 | 60,000 | |
| Jan 25 2019 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP, CHIEF OPERATIN ... | Sell | S | 45.26 | 20,000 | 905,178 | 666 | 20.7 K to 666 (-96.78 %) |
| Jan 25 2019 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP, CHIEF OPERATIN ... | Buy | M | 2.59 | 20,000 | 51,800 | 20,666 | 666 to 20.7 K (+3,003.00 %) |
| Nov 19 2018 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP, CHIEF OPERATIN ... | Grant | A | 16.92 | 676 | 11,438 | 1,454 | 778 to 1.5 K (+86.89 %) |
| Jun 15 2018 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP, CHIEF OPERATIN ... | Option Exercise | A | 18.86 | 100,000 | 1,886,000 | 100,000 | |
| Dec 05 2017 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP, CHIEF OPERATIN ... | Option Exercise | A | 2.59 | 100,000 | 259,000 | 100,000 | |
| May 18 2017 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP, CHIEF OPERATIN ... | Option Exercise | A | 0.90 | 105,000 | 94,500 | 105,000 | |
| Dec 16 2016 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP, CHIEF OPERATIN ... | Option Exercise | A | 2.30 | 169,200 | 389,160 | 169,200 | |
| Aug 03 2016 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP, CHIEF OPERATIN ... | Option Exercise | M | 1.11 | 15,000 | 16,589 | 87,040 | |
| Aug 03 2016 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP, CHIEF OPERATIN ... | Sell | S | 6.52 | 15,000 | 97,800 | 7,763 | 22.8 K to 7.8 K (-65.90 %) |
| Aug 03 2016 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP, CHIEF OPERATIN ... | Buy | M | 1.11 | 15,000 | 16,589 | 22,763 | 7.8 K to 22.8 K (+193.22 %) |
| May 16 2016 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP, CHIEF OPERATIN ... | Grant | A | 5.73 | 2,468 | 14,142 | 7,763 | 5.3 K to 7.8 K (+46.61 %) |
| May 02 2016 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP, CHIEF OPERATIN ... | Option Exercise | M | 1.11 | 2,000 | 2,212 | 102,040 | |
| May 02 2016 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP, CHIEF OPERATIN ... | Sell | S | 10.61 | 2,000 | 21,213 | 5,295 | 7.3 K to 5.3 K (-27.42 %) |
| May 02 2016 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP, CHIEF OPERATIN ... | Buy | M | 1.11 | 2,000 | 2,212 | 7,295 | 5.3 K to 7.3 K (+37.77 %) |
| Mar 09 2016 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP, CHIEF OPERATIN ... | Option Exercise | M | 1.11 | 4,000 | 4,424 | 106,040 | |
| Mar 09 2016 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP, CHIEF OPERATIN ... | Sell | S | 10.01 | 4,000 | 40,026 | 5,295 | 9.3 K to 5.3 K (-43.03 %) |
| Mar 09 2016 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP, CHIEF OPERATIN ... | Buy | M | 1.11 | 4,000 | 4,424 | 9,295 | 5.3 K to 9.3 K (+75.54 %) |
| Feb 17 2016 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP, CHIEF OPERATIN ... | Option Exercise | A | 6.95 | 84,600 | 587,970 | 84,600 | |
| Apr 22 2016 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP, CHIEF OPERATIN ... | Option Exercise | M | 1.11 | 2,000 | 2,212 | 104,040 | |
| Apr 22 2016 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP, CHIEF OPERATIN ... | Sell | S | 10.00 | 2,000 | 20,000 | 5,295 | 7.3 K to 5.3 K (-27.42 %) |
| Apr 22 2016 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP, CHIEF OPERATIN ... | Buy | M | 1.11 | 2,000 | 2,212 | 7,295 | 5.3 K to 7.3 K (+37.77 %) |
| Jan 05 2016 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP & CHIEF OPERATI ... | Option Exercise | M | 1.11 | 2,000 | 2,212 | 110,040 | |
| Jan 05 2016 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP & CHIEF OPERATI ... | Sell | S | 11.47 | 2,000 | 22,944 | 3,295 | 5.3 K to 3.3 K (-37.77 %) |
| Jan 05 2016 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP & CHIEF OPERATI ... | Buy | M | 1.11 | 2,000 | 2,212 | 5,295 | 3.3 K to 5.3 K (+60.70 %) |
| Dec 02 2015 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP & CHIEF OPERATI ... | Option Exercise | M | 1.11 | 2,000 | 2,212 | 112,040 | |
| Dec 02 2015 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP & CHIEF OPERATI ... | Sell | S | 10.14 | 2,000 | 20,280 | 4,084 | 6.1 K to 4.1 K (-32.87 %) |
| Dec 02 2015 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP & CHIEF OPERATI ... | Buy | M | 1.11 | 2,000 | 2,212 | 6,084 | 4.1 K to 6.1 K (+48.97 %) |
| Nov 03 2015 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP & CHIEF OPERATI ... | Option Exercise | M | 1.11 | 4,000 | 4,424 | 114,040 | |
| Nov 03 2015 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP & CHIEF OPERATI ... | Sell | S | 10.00 | 4,000 | 40,000 | 4,084 | 8.1 K to 4.1 K (-49.48 %) |
| Nov 03 2015 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP & CHIEF OPERATI ... | Buy | M | 1.11 | 4,000 | 4,424 | 8,084 | 4.1 K to 8.1 K (+97.94 %) |
| Sep 16 2015 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP & CHIEF OPERATI ... | Option Exercise | M | 1.11 | 2,000 | 2,212 | 118,040 | |
| Sep 16 2015 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP & CHIEF OPERATI ... | Sell | S | 12.51 | 2,000 | 25,020 | 4,084 | 6.1 K to 4.1 K (-32.87 %) |
| Sep 16 2015 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP & CHIEF OPERATI ... | Buy | M | 1.11 | 2,000 | 2,212 | 6,084 | 4.1 K to 6.1 K (+48.97 %) |
| Aug 07 2015 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP & CHIEF OPERATI ... | Option Exercise | M | 1.11 | 17,500 | 19,353 | 120,040 | |
| Aug 07 2015 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP & CHIEF OPERATI ... | Option Exercise | M | 1.11 | 17,500 | 19,353 | 137,540 | |
| Aug 07 2015 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP & CHIEF OPERATI ... | Sell | S | 12.19 | 17,500 | 213,399 | 4,084 | 21.6 K to 4.1 K (-81.08 %) |
| Aug 07 2015 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP & CHIEF OPERATI ... | Buy | M | 1.11 | 17,500 | 19,353 | 21,584 | 4.1 K to 21.6 K (+428.50 %) |
| Aug 07 2015 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP & CHIEF OPERATI ... | Sell | S | 12.70 | 17,500 | 222,189 | 4,084 | 21.6 K to 4.1 K (-81.08 %) |
| Aug 07 2015 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP & CHIEF OPERATI ... | Buy | M | 1.11 | 17,500 | 19,353 | 21,584 | 4.1 K to 21.6 K (+428.50 %) |
| May 22 2015 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP & CHIEF OPERATI ... | Option Exercise | A | 11.92 | 56,400 | 672,288 | 56,400 | |
| May 22 2015 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP & CHIEF OPERATI ... | Grant | A | 10.54 | 1,849 | 19,488 | 4,084 | 2.2 K to 4.1 K (+82.73 %) |
| May 01 2015 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP & CHIEF OPERATI ... | Option Exercise | M | 1.11 | 2,000 | 2,212 | 155,040 | |
| May 01 2015 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP & CHIEF OPERATI ... | Sell | S | 13.72 | 2,000 | 27,436 | 2,235 | 4.2 K to 2.2 K (-47.23 %) |
| May 01 2015 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP & CHIEF OPERATI ... | Buy | M | 1.11 | 2,000 | 2,212 | 4,235 | 2.2 K to 4.2 K (+89.49 %) |
| Apr 03 2015 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP & CHIEF OPERATI ... | Option Exercise | M | 1.11 | 2,000 | 2,212 | 157,040 | |
| Apr 03 2015 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP & CHIEF OPERATI ... | Sell | S | 12.47 | 2,000 | 24,939 | 2,235 | 4.2 K to 2.2 K (-47.23 %) |
| Apr 03 2015 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP & CHIEF OPERATI ... | Buy | M | 1.11 | 2,000 | 2,212 | 4,235 | 2.2 K to 4.2 K (+89.49 %) |
| Mar 04 2015 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP & CHIEF OPERATI ... | Option Exercise | M | 1.11 | 2,000 | 2,212 | 159,040 | |
| Mar 04 2015 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP & CHIEF OPERATI ... | Sell | S | 11.76 | 2,000 | 23,513 | 2,235 | 4.2 K to 2.2 K (-47.23 %) |
| Mar 04 2015 | TNDM | TANDEM DIABETES CA ... | Sheridan John F | EVP & CHIEF OPERATI ... | Buy | M | 1.11 | 2,000 | 2,212 | 4,235 | 2.2 K to 4.2 K (+89.49 %) |
Page: 1